158 related articles for article (PubMed ID: 34030202)
1. Chronic Lung Allograft Dysfunction: Evolving Concepts and Therapies.
Amubieya O; Ramsey A; DerHovanessian A; Fishbein GA; Lynch JP; Belperio JA; Weigt SS
Semin Respir Crit Care Med; 2021 Jun; 42(3):392-410. PubMed ID: 34030202
[TBL] [Abstract][Full Text] [Related]
2. Chronic Lung Allograft Dysfunction: Evolving Concepts and Therapies.
DerHovanessian A; Wallace WD; Lynch JP; Belperio JA; Weigt SS
Semin Respir Crit Care Med; 2018 Apr; 39(2):155-171. PubMed ID: 29579768
[TBL] [Abstract][Full Text] [Related]
3. The diagnosis and management of chronic lung allograft dysfunction.
Verleden GM; Hendriks JMH; Verleden SE
Curr Opin Pulm Med; 2024 Jul; 30(4):377-381. PubMed ID: 38305383
[TBL] [Abstract][Full Text] [Related]
4. Chronic lung allograft dysfunction: evolving practice.
Vos R; Verleden SE; Verleden GM
Curr Opin Organ Transplant; 2015 Oct; 20(5):483-91. PubMed ID: 26262458
[TBL] [Abstract][Full Text] [Related]
5. Validation of a post-transplant chronic lung allograft dysfunction classification system.
Van Herck A; Verleden SE; Sacreas A; Heigl T; Vanaudenaerde BM; Dupont LJ; Yserbyt J; Verbeken EK; Neyrinck AP; Van Raemdonck D; Verleden GM; Vos R
J Heart Lung Transplant; 2019 Feb; 38(2):166-173. PubMed ID: 30391199
[TBL] [Abstract][Full Text] [Related]
6. The healthcare resource utilization and costs of chronic lung allograft dysfunction following lung transplantation in patients with commercial insurance in the United States.
Sheshadri A; Sacks NC; Healey B; Cyr P; Boerner G; Huang HJ
J Med Econ; 2022; 25(1):650-659. PubMed ID: 35502563
[TBL] [Abstract][Full Text] [Related]
7. The potential of biomarkers of fibrosis in chronic lung allograft dysfunction.
van der Ploeg EA; Melgert BN; Burgess JK; Gan CT
Transplant Rev (Orlando); 2021 Jul; 35(3):100626. PubMed ID: 33992914
[TBL] [Abstract][Full Text] [Related]
8. Risk assessment of chronic lung allograft dysfunction phenotypes: Validation and proposed refinement of the 2019 International Society for Heart and Lung Transplantation classification system.
Levy L; Huszti E; Renaud-Picard B; Berra G; Kawashima M; Takahagi A; Fuchs E; Ghany R; Moshkelgosha S; Keshavjee S; Singer LG; Tikkanen J; Martinu T
J Heart Lung Transplant; 2020 Aug; 39(8):761-770. PubMed ID: 32418864
[TBL] [Abstract][Full Text] [Related]
9. Chronic lung allograft dysfunction: light at the end of the tunnel?
Verleden SE; Vos R; Verleden GM
Curr Opin Organ Transplant; 2019 Jun; 24(3):318-323. PubMed ID: 31090642
[TBL] [Abstract][Full Text] [Related]
10. Significance of phenotype change after chronic lung allograft dysfunction onset.
Fuchs E; Levy L; Huszti E; Renaud-Picard B; Berra G; Kawashima M; Takahagi A; Ghany R; Havlin J; McInnis MC; Keshavjee S; Singer LG; Tikkanen J; Chow CW; Martinu T
Transpl Int; 2021 Dec; 34(12):2620-2632. PubMed ID: 34748217
[TBL] [Abstract][Full Text] [Related]
11. Pharmacotherapy of chronic lung allograft dysfunction post lung transplantation.
Evans RA; Walter KS; Lobo LJ; Coakley R; Doligalski CT
Clin Transplant; 2022 Aug; 36(8):e14770. PubMed ID: 35801376
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of early pulmonary function changes after onset of chronic lung allograft dysfunction.
Todd JL; Neely ML; Finlen Copeland CA; Frankel CW; Reynolds JM; Palmer SM
J Heart Lung Transplant; 2019 Feb; 38(2):184-193. PubMed ID: 30466803
[TBL] [Abstract][Full Text] [Related]
13. Biomarkers for Chronic Lung Allograft Dysfunction: Ready for Prime Time?
Verleden SE; Hendriks JMH; Lauwers P; Yogeswaran SK; Verplancke V; Kwakkel-Van-Erp JM
Transplantation; 2023 Feb; 107(2):341-350. PubMed ID: 35980878
[TBL] [Abstract][Full Text] [Related]
14. Emerging biomarkers in chronic lung allograft dysfunction.
Shtraichman O; Diamond JM
Expert Rev Mol Diagn; 2020 May; 20(5):467-475. PubMed ID: 32133875
[No Abstract] [Full Text] [Related]
15. Incidence and impact of chronic lung allograft dysfunction after lung transplantation - single-center 14-year experience.
Nykänen A; Raivio P; Peräkylä L; Stark C; Huuskonen A; Lemström K; Halme M; Hämmäinen P
Scand Cardiovasc J; 2020 Jun; 54(3):192-199. PubMed ID: 32148103
[No Abstract] [Full Text] [Related]
16. Identification and characterization of chronic lung allograft dysfunction patients with mixed phenotype: A single-center study.
Verleden SE; Von Der Thüsen J; Van Herck A; Weynand B; Verbeken E; Verschakelen J; Dubbeldam A; Vanaudenaerde BM; Vos R; Verleden GM;
Clin Transplant; 2020 Feb; 34(2):e13781. PubMed ID: 31958356
[TBL] [Abstract][Full Text] [Related]
17. Update in Chronic Lung Allograft Dysfunction.
Shah RJ; Diamond JM
Clin Chest Med; 2017 Dec; 38(4):677-692. PubMed ID: 29128018
[TBL] [Abstract][Full Text] [Related]
18. Importance of the preoperative prognostic nutritional index score as a predictor of chronic lung allograft dysfunction after lung transplantation: a Japanese single-institution study.
Kanou T; Minami M; Funaki S; Ose N; Fukui E; Kimura K; Shintani Y
Surg Today; 2021 Dec; 51(12):1946-1952. PubMed ID: 33839934
[TBL] [Abstract][Full Text] [Related]
19. Donor-specific antibody characteristics, including persistence and complement-binding capacity, increase risk for chronic lung allograft dysfunction.
Iasella CJ; Ensor CR; Marrari M; Mangiola M; Xu Q; Nolley E; Moore CA; Morrell MR; Pilewski JM; Sanchez PG; McDyer JF; Zeevi A
J Heart Lung Transplant; 2020 Dec; 39(12):1417-1425. PubMed ID: 32981841
[TBL] [Abstract][Full Text] [Related]
20. [Development of Personalized and Targeted Preventive Therapies for Chronic Lung Allograft Dysfunction Subtypes;A Novel Strategy].
Saito T; Sato M; Taniguchi Y; Murakawa T; Keshavjee S
Kyobu Geka; 2016 Oct; 69(11):931-934. PubMed ID: 27713199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
